| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
From the Departments of Pathology,*Oncology,¶and Surgery,||and the Brady Urological Institute,The Johns Hopkins Medical Institutions, Baltimore, Maryland; and the Departments of Pathologyand Surgery,Academic Medical Center, Amsterdam, The Netherlands
A multistep model of carcinogenesis has recently been proposed for pancreatic ductal adenocarcinomas. In this model, noninvasive precursor lesions in the pancreatic ductules accumulate genetic alterations in cancer-associated genes eventually leading to the development of an invasive cancer. The nomenclature for these precursor lesions has been standardized as pancreatic intraepithelial neoplasia or PanIN. Despite the substantial advances made in understanding the biology of invasive pancreatic adenocarcinomas, little is known about the initiating genetic events in the pancreatic ductal epithelium that facilitates its progression to cancer. Telomeres are distinctive structures at the ends of chromosomes that protect against chromosomal breakage-fusion-bridge cycles in dividing cells. Critically shortened telomeres can cause chromosomal instability, a sine qua non of most human epithelial cancers. Although evidence for telomeric dysfunction has been demonstrated in invasive pancreatic cancer, the onset of this phenomenon has not been elucidated in the context of noninvasive precursor lesions. We used a recently described in situ hybridization technique in archival samples (Meeker AK, Gage WR, Hicks JL, Simon I, Coffman JR, Platz EA, March GE, De Marzo AM: Telomere length assessment in human archival tissues: combined telomere fluorescence in situ hybridization and immunostaining. American Journal of Pathology 2002, 160:1259–1268) for assessment of telomere length in tissue microarrays containing a variety of noninvasive pancreatic ductal lesions. These included 82 PanIN lesions of all histological grades (24 PanIN-1A, 23 PanIN-1B, 24 PanIN-2, and 11 PanIN-3) that were selected from pancreatectomy specimens for either adenocarcinoma or chronic pancreatitis. Telomere fluorescence intensities in PanIN lesions were compared with adjacent normal pancreatic ductal epithelium and acini (62 of 82 lesions, 76%), or with stromal fibroblasts and islets of Langerhans (20 of 82 lesions, 24%). Telomere signals were strikingly reduced in 79 (96%) of 82 PanINs compared to adjacent normal structures. Notably, even PanIN-1A, the earliest putative precursor lesion, demonstrated a dramatic reduction of telomere fluorescence intensity in 21 (91%) of 23 foci examined. In chronic pancreatitis, reduction of telomere signal was observed in all PanIN lesions, whereas atrophic and inflammatory ductal lesions retained normal telomere length. Telomere fluorescence intensity in PanIN lesions did not correlate with proliferation measured by quantitative Ki-67-labeling index or topoisomerase II
expression. Thus, telomere shortening is by far the most common early genetic abnormality recognized to date in the progression model of pancreatic adenocarcinomas. Telomeres may be an essential gatekeeper for maintaining chromosomal integrity, and thus, normal cellular physiology in pancreatic ductal epithelium. A critical shortening of telomere length in PanINs may predispose these noninvasive ductal lesions to accumulate progressive chromosomal abnormalities and to develop toward the stage of invasive carcinoma.
This article has been cited by other articles:
 |
|
 |
|
  S. E. Artandi and R. A. DePinho Telomeres and telomerase in cancer Carcinogenesis, January 1, 2010; 31(1): 9 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Zheng, N. Hu, Q. Sun, C. Wang, and P. R. Taylor Telomere Attrition in Cancer Cells and Telomere Length in Tumor Stroma Cells Predict Chromosome Instability in Esophageal Squamous Cell Carcinoma: A Genome-Wide Analysis Cancer Res., February 15, 2009; 69(4): 1604 - 1614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Akbay, C. M. Contreras, S. A. Perera, J. P. Sullivan, R. R. Broaddus, J. O. Schorge, R. Ashfaq, H. Saboorian, K.-K. Wong, and D. H. Castrillon Differential Roles of Telomere Attrition in Type I and II Endometrial Carcinogenesis Am. J. Pathol., August 1, 2008; 173(2): 536 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Feldmann and A. Maitra Molecular Genetics of Pancreatic Ductal Adenocarcinomas and Recent Implications for Translational Efforts J. Mol. Diagn., March 1, 2008; 10(2): 111 - 122. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Gold, Z. Karanjawala, D. E. Modrak, D. M. Goldenberg, and R. H. Hruban PAM4-Reactive MUC1 Is a Biomarker for Early Pancreatic Adenocarcinoma Clin. Cancer Res., December 15, 2007; 13(24): 7380 - 7387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Abe, N. Fukushima, K. Brune, C. Boehm, N. Sato, H. Matsubayashi, M. Canto, G. M. Petersen, R. H. Hruban, and M. Goggins Genome-Wide Allelotypes of Familial Pancreatic Adenocarcinomas and Familial and Sporadic Intraductal Papillary Mucinous Neoplasms Clin. Cancer Res., October 15, 2007; 13(20): 6019 - 6025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. DePinho Genetics and biology of pancreatic ductal adenocarcinoma. Genes & Dev., May 15, 2006; 20(10): 1218 - 1249. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Bardeesy, A. J. Aguirre, G. C. Chu, K.-h. Cheng, L. V. Lopez, A. F. Hezel, B. Feng, C. Brennan, R. Weissleder, U. Mahmood, et al. From the Cover: Both p16Ink4a and the p19Arf-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse PNAS, April 11, 2006; 103(15): 5947 - 5952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jimeno and M. Hidalgo Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol. Cancer Ther., April 1, 2006; 5(4): 787 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Kuang, Y. Xiao, X. Liu, T. M. Stringfield, S. Zhang, Z. Wang, and Y. Chen In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas PNAS, February 7, 2006; 103(6): 1858 - 1863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tassi, R. T. Henke, E. T. Bowden, M. R. Swift, D. P. Kodack, A. H. Kuo, A. Maitra, and A. Wellstein Expression of a Fibroblast Growth Factor-Binding Protein during the Development of Adenocarcinoma of the Pancreas and Colon Cancer Res., January 15, 2006; 66(2): 1191 - 1198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Karikari, M. Mullendore, J. R. Eshleman, P. Argani, L. M. Leoni, S. Chattopadhyay, M. Hidalgo, and A. Maitra Homozygous deletions of methylthioadenosine phosphorylase in human biliary tract cancers Mol. Cancer Ther., December 1, 2005; 4(12): 1860 - 1866. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Segara, A. V. Biankin, J. G. Kench, C. C. Langusch, A. C. Dawson, D. A. Skalicky, D. C. Gotley, M. J. Coleman, R. L. Sutherland, and S. M. Henshall Expression of HOXB2, a Retinoic Acid Signaling Target in Pancreatic Cancer and Pancreatic Intraepithelial Neoplasia Clin. Cancer Res., May 1, 2005; 11(9): 3587 - 3596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Hansel, A. Maitra, J. W. Lin, M. Goggins, P. Argani, C. J. Yeo, S. Piantadosi, S. D. Leach, and A. V. Biankin Expression of the Caudal-Type Homeodomain Transcription Factors CDX 1/2 and Outcome in Carcinomas of the Ampulla of Vater J. Clin. Oncol., March 20, 2005; 23(9): 1811 - 1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Prasad, A. V. Biankin, N. Fukushima, A. Maitra, S. Dhara, A. G. Elkahloun, R. H. Hruban, M. Goggins, and S. D. Leach Gene Expression Profiles in Pancreatic Intraepithelial Neoplasia Reflect the Effects of Hedgehog Signaling on Pancreatic Ductal Epithelial Cells Cancer Res., March 1, 2005; 65(5): 1619 - 1626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lantuejoul, J. C. Soria, L. Morat, P. Lorimier, D. Moro-Sibilot, L. Sabatier, C. Brambilla, and E. Brambilla Telomere Shortening and Telomerase Reverse Transcriptase Expression in Preinvasive Bronchial Lesions Clin. Cancer Res., March 1, 2005; 11(5): 2074 - 2082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D.A. TUVESON and S.R. HINGORANI Ductal Pancreatic Cancer in Humans and Mice Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 65 - 72. [Abstract] [PDF]
|
|
|
|
|
|
M. ARMANIOS and C.W. GREIDER Telomerase and Cancer Stem Cells Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 205 - 208. [Abstract] [PDF]
|
|
|
|
|
|
R. T. Henke, B. R. Haddad, S. E. Kim, J. D. Rone, A. Mani, J. M. Jessup, A. Wellstein, A. Maitra, and A. T. Riegel Overexpression of the Nuclear Receptor Coactivator AIB1 (SRC-3) during Progression of Pancreatic Adenocarcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6134 - 6142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Aguirre, C. Brennan, G. Bailey, R. Sinha, B. Feng, C. Leo, Y. Zhang, J. Zhang, J. D. Gans, N. Bardeesy, et al. High-resolution characterization of the pancreatic adenocarcinoma genome PNAS, June 15, 2004; 101(24): 9067 - 9072. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Meeker, J. L. Hicks, C. A. Iacobuzio-Donahue, E. A. Montgomery, W. H. Westra, T. Y. Chan, B. M. Ronnett, and A. M. De Marzo Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis Clin. Cancer Res., May 15, 2004; 10(10): 3317 - 3326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Montgomery, P. Argani, J. L. Hicks, A. M. DeMarzo, and A. K. Meeker Telomere Lengths of Translocation-Associated and Nontranslocation-Associated Sarcomas Differ Dramatically Am. J. Pathol., May 1, 2004; 164(5): 1523 - 1529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Meeker, J. L. Hicks, E. Gabrielson, W. M. Strauss, A. M. De Marzo, and P. Argani Telomere Shortening Occurs in Subsets of Normal Breast Epithelium as well as in Situ and Invasive Carcinoma Am. J. Pathol., March 1, 2004; 164(3): 925 - 935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kondo, N. Oue, K. Yoshida, Y. Mitani, K. Naka, H. Nakayama, and W. Yasui Expression of POT1 is Associated with Tumor Stage and Telomere Length in Gastric Carcinoma Cancer Res., January 15, 2004; 64(2): 523 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Aguirre, N. Bardeesy, M. Sinha, L. Lopez, D. A. Tuveson, J. Horner, M. S. Redston, and R. A. DePinho Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma Genes & Dev., December 15, 2003; 17(24): 3112 - 3126. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-K. Wong and R. A. DePinho Walking the Telomere Plank Into Cancer J Natl Cancer Inst, August 20, 2003; 95(16): 1184 - 1186. [Full Text] [PDF]
|
|
|
|
|
|
P. A. Farazi, J. Glickman, S. Jiang, A. Yu, K. L. Rudolph, and R. A. DePinho Differential Impact of Telomere Dysfunction on Initiation and Progression of Hepatocellular Carcinoma Cancer Res., August 15, 2003; 63(16): 5021 - 5027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Hansel, A. Rahman, M. Hidalgo, P. J. Thuluvath, K. D. Lillemoe, R. Shulick, J.-L. Ku, J.-G. Park, K. Miyazaki, R. Ashfaq, et al. Identification of Novel Cellular Targets in Biliary Tract Cancers Using Global Gene Expression Technology Am. J. Pathol., July 1, 2003; 163(1): 217 - 229. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
